About TRIFARMA
TRIFARMA is a Healthcare company based in Milan (Italy) founded in 1983, and was acquired by Principia SGR in July 2017. APIs and pharmaceutical intermediates are manufactured by TRIFARMA. TRIFARMA offers products and services including Antiinfective APIs, Cardiovascular APIs, Nervous System APIs, Dermatological APIs, and Steroids APIs. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is Trifarma S.p.A.
Company details
TRIFARMA was established in 1983 and is based in Milan, Italy. Operations focus on the production of active pharmaceutical ingredients (APIs) and related intermediates within the pharmaceutical sector. Manufacturing processes are conducted to support global supply chains, with emphasis on quality standards for drug development. The companys domain, trifarma.it, facilitates industry connections, and activities are centered in the European pharmaceutical market.
- Headquarters Milan, Italy
- Stage Acquired
- SectorsHealthcare
- Website trifarma.it
- Social LinkedIn
- Acquired by Principia SGR (Jul 2017)
- Legal Name Trifarma S.P.A.
- Investors
- Acquired byPrincipia SGR
(Jul 2017)
Products & Services of TRIFARMA
TRIFARMA offers a comprehensive portfolio of products and services, including Antiinfective APIs, Cardiovascular APIs, Nervous System APIs, Dermatological APIs, and Steroids APIs.
APIs used for treating bacterial and infectious diseases.
APIs for managing heart and blood vessel conditions.
APIs targeting neurological and psychiatric disorders.
APIs for skin and eye-related treatments.
APIs for hormonal and anti-inflammatory applications.
Investors in TRIFARMA
TRIFARMA has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Principia SGR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments in Italian tech and life sciences are targeted. | principiasgr.it | Milano, Italy |
Investor details for TRIFARMA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TRIFARMA
7 people are tracked at TRIFARMA (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Riccardo Anzuini | CEO | Leadership |
Renzo Percossi | Director, Strategic Projects Mabagement | Leadership |
Carlo Colombo | Chief Operating Officer | Leadership |
Margherita Genovese | Group CFO | Leadership |
Francesca Nadia Melzi | Quality Assurance Specialist | Team |
Irene Billari | Human Resources Management And The Law | Team |
Paolo Lugo | QA Manager & QP | Team |
Complete people profiles for TRIFARMA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TRIFARMA
2 dated milestones of TRIFARMA across 34 years, from founding to its latest funding, stage changes and deals.
- Founded TRIFARMA is founded.
- Exit Acquired by Principia SGR.
Web traffic of TRIFARMA
The website of TRIFARMA (trifarma.it) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 420.4% vs previous month
Websites whose visitors overlap most with TRIFARMA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| novacell.com | 100% | 1.9K | #8,657,904 | View details | |
krka.it | krka.it | 99% | #8,562,208 | – | |
| advicepharma.com | 99% | 1.2K | #10,282,879 | View details | |
| sibyllabiotech.it | 86% | 1.3K | #11,298,379 | View details | |
galenia.it | galenia.it | 77% | #3,872,338 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TRIFARMA
TRIFARMA was founded in 1983.
TRIFARMA is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
TRIFARMA was established in 1983 and is based in Milan, Italy. Operations focus on the production of active pharmaceutical ingredients (APIs) and related intermediates within the pharmaceutical sector. Manufacturing processes are conducted to support global supply chains, with emphasis on quality standards for drug development. The companys domain, trifarma.it, facilitates industry connections, and activities are centered in the European pharmaceutical market.
TRIFARMA offers Antiinfective APIs, Cardiovascular APIs, Nervous System APIs, Dermatological APIs, and Steroids APIs.
TRIFARMA has 1 investor. Key investors include Principia SGR.
TRIFARMA operates through Trifarma S.P.A..
Yes. TRIFARMA was acquired by Principia SGR in July 2017.